Multiple sclerosis and SARS-CoV-2: has the interplay started?

G Bellucci, V Rinaldi, MC Buscarinu, R Reniè… - Frontiers in …, 2021 - frontiersin.org
Current knowledge on Multiple Sclerosis (MS) etiopathogenesis encompasses complex
interactions between the host's genetic background and several environmental factors that …

Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology …

G Morris, M Maes - BMC medicine, 2013 - Springer
Background 'Encephalomyelitis disseminata'(multiple sclerosis) and myalgic
encephalomyelitis/chronic fatigue syndrome (ME/CFS) are both classified as diseases of the …

Potential pathophysiological pathways that can explain the positive effects of exercise on fatigue in multiple sclerosis: a scoping review

M Langeskov-Christensen, EJ Bisson… - Journal of the …, 2017 - Elsevier
Background Fatigue is one of the most common and most disabling symptoms of multiple
sclerosis (MS). It is a multidimensional and complex symptom with multifaceted origins …

Impaired sleep-associated modulation of post-exercise corticomotor depression in multiple sclerosis

A Bridoux, A Créange, A Sangare, SS Ayache… - Journal of the …, 2015 - Elsevier
Objective To compare the beneficial effect of nap versus rest on the recovery of motor
evoked potentials (MEPs) after a fatiguing exercise performed in patients with multiple …

Bilateral reversible corneal edema associated with amantadine use

S Esquenazi - Journal of ocular pharmacology and therapeutics, 2009 - liebertpub.com
Purpose: In this article, we report a case of bilateral severe reversible corneal edema
caused by amantadine therapy. Case: A 39-year-old women was referred to us for …

Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis

P Manceau, C Latarche, S Pittion, G Edan, J de Sèze… - BMC neurology, 2014 - Springer
Background The clinical impact of neutralizing antibodies against interferon-beta (NAb) is
controversial. Their presence can lead to a decrease in interferon-beta (IFNβ) efficacy …

Fatigue in multiple sclerosis

R Homorodean, DC Leucuţa… - Human and …, 2016 - search.proquest.com
Fatigue is a nonspecific but common symptom in multiple sclerosis (MS). It represents a
major cause of disability, affecting the quality of life of MS patients. Most studies on MS …

Fatigue as the presenting symptom of chronic inflammatory demyelinating polyneuropathy

V Bissay, A Flamez, E Schmedding… - Muscle & Nerve …, 2008 - Wiley Online Library
Different clinical presentations of chronic inflammatory demyelinating polyneuropathy
(CIDP) have been described. Fatigue is generally considered to be a secondary sign and is …

Evaluation der Verwendung von Virtueller Realität (VR) als Ergänzung zum Laufbandtraining im Rahmen der Behandlung von Gangstörungen bei Patienten mit …

C Winter - 2022 - opus.bibliothek.uni-wuerzburg.de
Die Rehabilitation von Gangstörungen bei Patienten mit MS und Schlaganfall erfolgt häufig
mithilfe eines konventionellen Laufbandtrainings. Einige Studien haben bereits gezeigt …

[PDF][PDF] Effect of resistance training on dehydroepiandrestrone sulfate levels and fatigue in women with multiple sclerosis disease

S Rashidfar, M Moghadasi, MA Edalatmanesh - 2013 - researchgate.net
Multiple Sclerosis (MS) is an autoimmune genetic disease that associated with chronic
inflammation of the central nervous system, demyelization, axonal loss, and brain atrophy …